FDA appeals making 'morning-after' pill available to all ages
By Terry Baynes (Reuters) - The Food and Drug Administration on Wednesday appealed a court order directing the agency to make "morni...
Read More »
By Terry Baynes (Reuters) - The Food and Drug Administration on Wednesday appealed a court order directing the agency to make "morni...
Read More »WASHINGTON (Reuters) - Employer-sponsored healthcare plans cannot include most "wellness programs" as part of minimum coverage requi...
Read More »
By Kate Kelland LONDON (Reuters) - A new strain of bird flu that is causing a deadly outbreak among people in China is a threat to w...
Read More »(Reuters) - Drugs from Amgen Inc, Teva Pharmaceutical Industries and Sanofi that boost white blood cells are being evaluated by U.S....
Read More »By Kerry Grens NEW YORK (Reuters Health) - Evening primrose oil doesn't reduce the symptoms of the itchy skin problem eczema, accord...
Read More »
By Esha Dey and Ransdell Pierson (Reuters) - Allergan Inc said approval of its Darpin eye drug could be delayed up to two years, pro...
Read More »
By Jessica Dye NEW YORK (Reuters) - Reproductive-rights groups that sued the Food and Drug Administration over access to the "mornin...
Read More »By Julie Steenhuysen CHICAGO (Reuters) - The first-ever drug designed to treat social impairments associated with autism failed to s...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - A change to a U.S. program that provides food and medical visits to many infants, ch...
Read More »By Toni Clarke (Reuters) - U.S. health regulators rejected an experimental drug to treat opioid addiction made by Titan Pharmaceutic...
Read More »